What is Arcadia?
Founded in 2002 and headquartered in Burlington, Massachusetts, Arcadia has established itself as a leading vendor in the health IT space. The company specializes in providing advanced data analytics and population health management platforms that empower healthcare organizations to navigate the complexities of modern clinical environments. Recognized by industry analysts such as Gartner, Chilmark, and KLAS, Arcadia serves a diverse client base across the United States, offering tools that integrate disparate data sources into actionable insights.
The firm's market position is defined by its deep expertise in health information technology, enabling it to support ACOs, health systems, and payers in their digital transformation journeys. By focusing on interoperability and high-quality data, Arcadia remains at the forefront of the shift toward more efficient, data-informed healthcare delivery models.
How much funding has Arcadia raised?
Arcadia has raised a total of $168M across 3 funding rounds:
Private Equity
$13M
Private Equity
$30M
Other Financing Round
$125M
Private Equity (2015): $13M with participation from Zaffre Investments and Peloton Equity
Private Equity (2017): $30M led by Zaffre Investments, Morgan Stanley Alternative Investment Partners, Peloton Equity, and GE Ventures
Other Financing Round (2023): $125M supported by Vista Equity Partners
Key Investors in Arcadia
Vista Equity Partners
A leading global investment firm that exclusively invests in enterprise software, data, and technology-enabled organizations, focusing on creating enduring market value.
Zaffre Investments
A subsidiary of Blue Cross Blue Shield of Massachusetts that invests in healthcare technologies aimed at improving delivery and patient outcomes.
Peloton Equity
A growth capital investor specializing in the healthcare sector, partnering with companies that demonstrate strong leadership and significant growth potential.
What's next for Arcadia?
With the recent influx of capital, Arcadia is well-positioned to accelerate its product development roadmap and expand its footprint in the enterprise software market. The strategic focus will likely center on enhancing its core analytics capabilities, deepening its integration with existing clinical workflows, and scaling its operations to meet the rising demand for sophisticated population health management tools.
Looking ahead, the company is expected to leverage its strong investor partnerships to explore new market opportunities and potentially broaden its service offerings. As the regulatory and economic environment for healthcare continues to evolve, Arcadia's commitment to innovation and its proven track record of delivering value to its partners suggest a continued trajectory of growth and industry leadership.
